Tag Archives: Complete

Immunotherapy provides a complete response to stage IV lung cancer

A recent case report was published in Onconscience (Volume 11) dated October 8, 2024, titled “Complete and Long-Term Response to Immunotherapy in Stage IV Non-Petite Cell Lung Cancer with Brain Metastases.” As highlighted in the summary of this report, approximately 20% of lung cancer patients have brain metastases at the time of diagnosis, which is […]

Complete neoadjuvant therapy shows promising results in the treatment of rectal cancer

In a recent prospective observational cohort study published in eMedicineClinicalResearchers evaluated a modified total neoadjuvant treatment (TNT) regimen in patients with high-risk locally advanced rectal cancer (LARC) in Sweden. The modified TNT regimen was found to achieve similar complete response (CR) rates and lower neurotoxicity compared with the RAPIDO study, despite treating older patients with […]